Position in SCLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$245,511
-$223,748 QoQ
Shares Held
36,864
-4.2% QoQ
Ownership
0.434%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $774,953,849 across 9 Drug Manufacturers - General names. SCLX ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,152,528 | $299,997,827 | |
| 2 | NVS |
Novartis AG
|
1,111,833 | $169,832,490 | |
| 3 | NVO |
Novo Nordisk A S
|
3,397,121 | $124,844,196 | |
| 4 | LLY |
ELI LILLY & Co
|
71,788 | $66,028,448 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
977,051 | $59,258,143 | |
| 6 | BIIB |
Biogen Inc.
|
203,396 | $37,288,588 | |
| 7 | GSK |
GSK plc
|
311,292 | $17,180,205 | |
| 8 | AMRN |
Amarin Corp Plc\Uk
|
19,256 | $278,441 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $245,511 | 36,864 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $469,259 | 38,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $377,146 | 19,164 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||